Drug Costs
61 - 80 of 693 Results
-
-
Perspective
With TV Drug Ads, What You See Is Not Necessarily What You Get
The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.
-
For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.
-
New Lines of Attack Form Against the Affordable Care Act
While fighting potential fraud in government programs has long been a conservative rallying cry, recent criticisms of the Affordable Care Act represent a renewed line of attack on the program when repealing it is unlikely.
-
How Little Denmark Got Homegrown Giant Novo Nordisk To Lower Ozempic Prices
As Congress pushes for Medicare to cover payment for anti-obesity drugs, Denmark 鈥 Ozempic maker Novo Nordisk鈥檚 home 鈥 has limited coverage of the drug after cost overruns 鈥渆mptied all the money boxes in the entire public health system.鈥
By Arthur Allen -
Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma鈥檚 Weight Loss Drugs
Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.
By Arthur Allen -
Harris, Once Biden鈥檚 Voice on Abortion, Would Take an Outspoken Approach to Health
If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access 鈥 hitting former President Donald Trump on an issue that could undermine his chances of victory.
At GOP Convention, Health Policy Is Mostly MIA
Episode 356After an assassination attempt last weekend sent former President Donald Trump to the hospital with minor injuries, the Republican National Convention went off with little mention of health care issues. And Trump鈥檚 newly nominated vice presidential pick, Sen. J.D. Vance of Ohio, has barely staked out a record on health during his 18 months in office 鈥 aside from being strongly opposed to abortion. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Joanne Kenen of Johns Hopkins University and Politico Magazine join 麻豆女优 Health News鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews 麻豆女优 Health News鈥 Renuka Rayasam, who wrote June鈥檚 installment of 麻豆女优 Health News-NPR 鈥淏ill of the Month,鈥 about a patient who walked into what he thought was an urgent care center and walked out with an emergency room bill.鈥
-
Trump Is Wrong in Claiming Full Credit for Lowering Insulin Prices
Though the Trump administration established a voluntary, temporary program lowering insulin costs for some older Americans on Medicare, the mandatory price caps implemented through Biden鈥檚 Inflation Reduction Act go significantly further.
-
1st Biden-Trump Debate of 2024: What They Got Wrong, and Right
A debate marked by President Joe Biden鈥檚 faltering performance featured clashes over insulin costs, inflation, abortion, immigration, and Jan. 6.
-
-
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment
The makers of Ozempic and Mounjaro charge list prices of around $1,000 a month for the diabetes and obesity drugs, and insurers are reluctant to pick up the tab. Often, low-income patients have to resort to less effective treatments.
-
Readers Speak Up About Women’s Health Issues, From Reproductive Care to Drinking
麻豆女优 Health News gives readers a chance to comment on a recent batch of stories.
-
Biden Is Right About $35 Insulin Cap but Exaggerates Prior Costs for Medicare Enrollees
Most Medicare enrollees likely were not paying a monthly average of $400 鈥 as President Joe Biden stated 鈥 before the insulin cap took effect. However, because costs and other factors result in widely varying prices, some Medicare enrollees might have paid that much in a given month.
Florida Limits Abortion 鈥 For Now
Episode 341The Florida Supreme Court handed down dual abortion rulings this week. One said voters will be allowed to decide in November whether to create a state right to abortion. The other ruling, though, allows a 15-week ban to take effect immediately 鈥 before an even more sweeping, six-week ban replaces it in May. Meanwhile, President Joe Biden is doubling down on his administration鈥檚 health care accomplishments as he kicks off his general election campaign. Lauren Weber of The Washington Post, Joanne Kenen of the Johns Hopkins University schools of nursing and public health, and Tami Luhby of CNN join 麻豆女优 Health News鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews health care analyst Jeff Goldsmith about the growing size and influence of UnitedHealth Group in the wake of the Change Healthcare hack.
-
The ACA Turns 14
Episode 339Saturday marks the 14th anniversary of the still somewhat embattled Affordable Care Act. Health and Human Services Secretary Xavier Becerra joins host Julie Rovner to discuss the accomplishments of the health law 鈥 and the challenges it still faces. Also this week, Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Mary Agnes Carey of 麻豆女优 Health News join Rovner to discuss what should be the final funding bill for HHS for fiscal 2024, next week鈥檚 Supreme Court oral arguments in a case challenging abortion medication, and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
-
麻豆女优 Health News & PolitiFact HealthCheck
Biden Said Medicare Drug Price Negotiations Cut the Deficit by $160B. That’s Years Away.
Savings estimated by the Congressional Budget Office from allowing the federal government to negotiate Medicare drug prices are based on a 10-year cumulative projection.
-
-
When Copay Assistance Backfires on Patients
Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.